Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Trientine dihydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Trientine dihydrochloride 200mg capsules
0908010S0AAACAC
|
Trientine dihydrochloride | Trientine dihydrochloride | Nutrition and Blood | 18 |
|
Cufence 100mg capsules
0908010S0BCABAE
|
Cufence | Trientine dihydrochloride | Nutrition and Blood | No data available |
|
Cufence 200mg capsules
0908010S0BCAAAC
|
Cufence | Trientine dihydrochloride | Nutrition and Blood | No data available |
|
Metalite 250mg capsules
0908010S0BBAAAD
|
Metalite | Trientine dihydrochloride | Nutrition and Blood | No data available |
|
Trientine dihydrochloride 100mg capsules
0908010S0AAAEAE
|
Trientine dihydrochloride | Trientine dihydrochloride | Nutrition and Blood | No data available |
|
Trientine dihydrochloride 250mg capsules
0908010S0AAADAD
|
Trientine dihydrochloride | Trientine dihydrochloride | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.